CRNX - Crinetics Pharmaceuticals, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
41.91 1.09 (2.6%) 0.02 (0.05%) -0.12 (-0.28%) -0.35 (-0.82%) 0.06 (0.14%) 1.39 (3.34%) --- 0.06 (0.14%)

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.23
Diluted EPS:
-1.23
Basic P/E:
-34.9593
Diluted P/E:
-34.9593
RSI(14) 1m:
37.45
VWAP:
43.03
RVol:

Events

Period Kind Movement Occurred At

Related News